ASH 2018

ASH successes set to lift Imbruvica in CLL
Biopharma Dive
Thu, 12/6/18 - 07:01 pm
AbbVie
Imbruvica
CLL
JNJ
ASH 2018
ASH: J&J's fast-growing Darzalex lines up for second front-line myeloma OK
Fierce Pharma
Tue, 12/4/18 - 11:33 am
JNJ
Darzalex
Multiple Myeloma
ASH 2018
ASH18: New data can’t lift Bluebird Bio’s depressed shares
Fierce Biotech
Tue, 12/4/18 - 10:02 am
Bluebird Bio
ASH 2018
ASH: Seattle Genetics rolls into latest Adcetris launch with double survival win
Fierce Biotech
Tue, 12/4/18 - 09:41 am
Seattle Genetics
Adcetris
ASH 2018
T-cell lymphoma
Weekend ASH presentations hint at future of BCMA CARs
BioCentury
Tue, 12/4/18 - 09:39 am
ASH 2018
BCMA
CAR-T
Multiple Myeloma
ASH18: Legend's CAR-T brought back to reality
Biopharma Dive
Mon, 12/3/18 - 10:53 pm
Legend Biotech
ASH 2018
CAR-T
Multiple Myeloma
#ASH18: Allogene ticks off a high CR rate for updated off-the-shelf CAR-T pioneer. But getting just the right kind of immunosuppression is crucial
Endpoints
Mon, 12/3/18 - 10:50 pm
ASH 2018
Allogene
CAR-T
ALL